Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q2 EPS of ($0.55), $0.04 worse than the analyst estimate of ($0.51).Recent Corporate DevelopmentsThe ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE